Brief: BB Biotech Says CHF 448 MLN Net Profit In Q3 2025
24/10/2025 06:05
Oct 24 (Reuters) - BB BIOTECH AG BION.S: REPORTS CHF 448 MILLION NET PROFIT IN Q3 2025 NAV ADVANCED 24.0% IN CHF (EUR +24.0% / USD +23.5%), MACRO CONDITIONS IMPROVED: FED'S SEPTEMBER RATE CUT AND MODERATING INFLATION BOOSTED RISK APPETITE Source text: ID:nEQ1wBTgla Further company coverage: BION.S (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com ; +48 587785269;;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM